— Michael Saylor, MicroStrategy
Michael Saylor keeps diluting MSTR holders after preferred sale flops
Fans of Michael Saylor believed that non-dilutive preferred shares would displace dilutive ATMs, but MicroStrategy just admitted the opposite.
62 stories, newest first
— Michael Saylor, MicroStrategy
Fans of Michael Saylor believed that non-dilutive preferred shares would displace dilutive ATMs, but MicroStrategy just admitted the opposite.
— Michael Saylor, MicroStrategy
Michael Saylor has unveiled a magically bullish calculator to evaluate the credit and BTC risks of MicroStrategy debt.
— Michael Saylor, MicroStrategy
MicroStrategy insiders have sold tens of millions of dollars worth of MSTR stock over the last three months.
Michael Saylor has made no secret of his BTC accumulation strategy and wants his fans to believe he can accomplish accretive dilution.
— Carl Rickertsen, MicroStrategy
MicroStrategy's Carl Rickertsen sold over $10M this year, admitted zero ownership, and continued an uninterrupted series of insider sales.
Looking at a chart of BTC when MicroStrategy was buying last week, skeptics think Michael Saylor paid nearly the worst price possible.
As BTC crashed below the price at which Michael Saylor suggested selling a kidney, he reminded us that its price never declines in BTC terms.
MicroStrategy didn’t buy any BTC last week. Not only that, MSTR shareholders don’t even own the company’s BTC.
— Michael Saylor, MicroStrategy
Although dividend and liquidation preference numbers for Strategy’s STRF appear unchanged, initial buyers are getting a de facto discount.
— Michael Saylor, MicroStrategy
Michael Saylor has invented yet another way to raise capital to buy BTC for Strategy: STRF preferreds with higher cash dividends.